MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T
Status PubMed-not-MEDLINE Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
27489865
PubMed Central
PMC4959510
DOI
10.1212/nxi.0000000000000259
PII: NEURIMMINFL2015008821
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: To characterize paramagnetic MRI phase signal abnormalities in neuromyelitis optica spectrum disorder (NMOSD) vs multiple sclerosis (MS) lesions in a cross-sectional study. METHODS: Ten patients with NMOSD and 10 patients with relapsing-remitting MS underwent 7-tesla brain MRI including supratentorial T2*-weighted imaging and supratentorial susceptibility weighted imaging. Next, we analyzed intra- and perilesional paramagnetic phase changes on susceptibility weighted imaging filtered magnetic resonance phase images. RESULTS: We frequently observed paramagnetic rim-like (75 of 232 lesions, 32%) or nodular (32 of 232 lesions, 14%) phase changes in MS lesions, but only rarely in NMOSD lesions (rim-like phase changes: 2 of 112 lesions, 2%, p < 0.001; nodular phase changes: 2 of 112 lesions, 2%, p < 0.001). CONCLUSIONS: Rim-like or nodular paramagnetic MRI phase changes are characteristic for MS lesions and not frequently detectable in NMOSD. Future prospective studies should ask whether these imaging findings can be used as a biomarker to distinguish between NMOSD- and MS-related brain lesions.
Zobrazit více v PubMed
Jarius S, Ruprecht K, Wildemann B, et al. . Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation 2012;9:14. PubMed PMC
Wingerchuk DM, Banwell B, Bennett JL, et al. . International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85:177–189. PubMed PMC
Sinnecker T, Dörr J, Pfueller CF, et al. . Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology 2012;79:708–714. PubMed
Kister I, Herbert J, Zhou Y, Ge Y. Ultrahigh-field MR (7 T) imaging of brain lesions in neuromyelitis optica. Mult Scler Int 2013;2013:398259. PubMed PMC
Hagemeier J, Heininen-Brown M, Gabelic T, et al. . Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders. AJNR Am J Neuroradiol 2014;35:1916–1923. PubMed PMC
Polman CH, Reingold SC, Banwell B, et al. . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302. PubMed PMC
Pitt D, Boster A, Pei W, et al. . Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging. Arch Neurol 2010;67:812–818. PubMed
Absinta M, Sati P, Gaitán MI, et al. . Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process. Ann Neurol 2013;74:669–678. PubMed PMC
Bian W, Harter K, Hammond-Rosenbluth KE, et al. . A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis. Mult Scler 2013;19:69–75. PubMed
Hametner S, Wimmer I, Haider L, Pfeifenbring S, Brück W, Lassmann H. Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 2013;74:848–861. PubMed PMC
Bagnato F, Hametner S, Yao B, et al. . Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 tesla. Brain 2011;134(pt 12):3602–3615. PubMed PMC
Li W, Wu B, Liu C. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. Neuroimage 2011;55:1645–1656. PubMed PMC
Brück W, Popescu B, Lucchinetti CF, et al. . Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate. Ann Neurol 2012;72:385–394. PubMed
Habib CA, Liu M, Bawany N, et al. . Assessing abnormal iron content in the deep gray matter of patients with multiple sclerosis versus healthy controls. AJNR Am J Neuroradiol 2012;33:252–258. PubMed PMC
Chen X, Zeng C, Luo T, et al. . Iron deposition of the deep grey matter in patients with multiple sclerosis and neuromyelitis optica: a control quantitative study by 3D-enhanced susceptibility-weighted angiography (ESWAN). Eur J Radiol 2012;81:e633–e639. PubMed
Chen W, Gauthier SA, Gupta A, et al. . Quantitative susceptibility mapping of multiple sclerosis lesions at various ages. Radiology 2014;271:183–192. PubMed PMC
Kim HJ, Paul F, Lana-Peixoto MA, et al. . MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 2015;84:1165–1173. PubMed PMC
Cerebral Iron Deposition in Neurodegeneration
Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis